Parliament, Wednesday, 24 June 2020 – The Chairperson of the Portfolio Committee on Health, Dr Sibongiseni Dhlomo, has applauded the team of the University of Witwatersrand researchers for their work in the first clinical trial in South Africa for a Covid-19 vaccine.
	
	The announcement of the South African Ox1Cov-19 Vaccine VIDA trial was made yesterday, with the aim of finding a vaccine that will prevent infection by SARS-CoV-2, the virus that causes Covid-19.
	
	Dr Dhlomo said the news of this breakthrough in fighting the pandemic “begins to allay the fears among our people and health workers. We hope that the team will do everything to accelerate such a noble programme. It will bring us closer to our world-expected dream vaccine against Covid-19”.
	
	ISSUED BY THE PARLIAMENTARY COMMUNICATION SERVICES ON BEHALF OF THE CHAIRPERSON OF THE PORTFOLIO COMMITTEE ON HEALTH, DR SIBONGISENI DHLOMO.
	
	For media enquiries or interviews with the Chairperson, please contact the committee’s Media Officer:
	Name: Ms Yoliswa Landu
	Parliamentary Communication Services
	Tel: 021 403 8203
	Cell: 081 497 4694
	E-mail: ylandu@parliament.gov.za The Constitution says a parliamentary committee meeting may not be closed to the public “unless it is reasonable and justifiable to do so in an open and democratic society”. African National Congress on the National List